Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
July 28, 2026
Just because a motion is unopposed doesn't mean it should be granted, Michigan appellate judges said in a published opinion Tuesday, reversing a trial court's decision that the Pandemic Health Care Immunity Act shielded Beaumont Hospital Farmington Hills from a medical malpractice suit.
-
July 28, 2026
The real story of the U.S. Supreme Court’s recent ruling in T.M. v. University of Maryland Medical System Corp., finding that a doctrine designed to curtail duplicative litigation prevents federal district courts from reviewing state court decisions, is in how the justices together revisited an obscure, century-old jurisdictional doctrine, says Alex Dimitrief at Zeughauser Group.
-
July 28, 2026
A woman agreed to permanently end her lawsuit against medical device manufacturer Zimmer Biomet, which claimed its compound for bonding prosthetics to bone was defective and caused her to suffer following a knee replacement surgery.
-
July 28, 2026
Drugmakers will be pressing appellate judges in the back half of 2026 to strike down state laws blocking them from imposing restrictions on 340B contract pharmacy arrangements. Law360 Healthcare Authority has the cases to watch.
-
July 28, 2026
A Pennsylvania federal judge has taken Teva to task for trying to avoid being held to its admissions of price-fixing in a $225 million settlement with the U.S. Department of Justice, ruling that Humana can use those admissions in one of the first bellwether trials in sprawling multidistrict litigation.
See more Life Sciences news